Praxis Precision Medicines Inc banner

Praxis Precision Medicines Inc
NASDAQ:PRAX

Watchlist Manager
Praxis Precision Medicines Inc Logo
Praxis Precision Medicines Inc
NASDAQ:PRAX
Watchlist
Price: 342.71 USD 0.07%
Market Cap: $9.4B

Intrinsic Value

The intrinsic value of one PRAX stock under the Base Case scenario is hidden USD. Compared to the current market price of 342.71 USD, Praxis Precision Medicines Inc is hidden .

PRAX Intrinsic Value
HIDDEN
Show

Valuation History
Praxis Precision Medicines Inc

Intrinsic Value History
Dive into the past to invest in the future

PRAX looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PRAX usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about PRAX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PRAX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Praxis Precision Medicines Inc.

Explain Valuation
Compare PRAX to

Wall St
Price Targets

Dividends

Praxis Precision Medicines Inc
does not pay dividends
Shareholder Yield
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Ownership

PRAX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PRAX stock?

The intrinsic value of one PRAX stock under the Base Case scenario is hidden USD.

Is PRAX stock undervalued or overvalued?

Compared to the current market price of 342.71 USD, Praxis Precision Medicines Inc is hidden .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett